6-MAPDB

6-MAPDB

Error creating thumbnail:

Chemical structure of 6-MAPDB

6-MAPDB is a synthetic compound that belongs to the class of phenethylamines. It is structurally related to other compounds in the benzodioxole family, which are known for their psychoactive properties. 6-MAPDB is of interest in the field of neuropharmacology due to its potential effects on the central nervous system.

Chemical Structure

6-MAPDB, or 6-(2-methylaminopropyl)-2,3-dihydrobenzofuran, is characterized by its benzofuran core structure. The presence of a methylamino group at the 2-position of the propyl chain is a key feature that influences its pharmacological activity. The chemical structure of 6-MAPDB is similar to that of other entactogens and empathogens, which are known to affect serotonin release and reuptake.

Pharmacology

6-MAPDB is believed to act primarily as a serotonin releasing agent (SRA), similar to other compounds in its class. This action is thought to be responsible for its potential psychoactive effects, which may include altered mood, perception, and cognition. The exact mechanism of action of 6-MAPDB is not fully understood, and research is ongoing to elucidate its effects on the brain.

Potential Uses

While 6-MAPDB is not approved for any medical use, it is studied for its potential applications in psychotherapy and psychiatry. Compounds with similar structures have been investigated for their ability to enhance empathy and emotional processing, which could be beneficial in therapeutic settings.

Legal Status

The legal status of 6-MAPDB varies by country. In some jurisdictions, it is classified as a controlled substance due to its structural similarity to other psychoactive compounds. Researchers must adhere to strict regulations when studying 6-MAPDB to ensure compliance with local laws.

Related Pages

• Phenethylamine
• Benzodioxole
• Serotonin releasing agent
• Psychoactive drug